Case reports and case series have documented instances of severe, persistent gastroparesis temporally associated with GLP-1 initiation, with some patients requiring hospitalization for refractory nausea and vomiting
Let your body adapt to one major change before introducing another
2 2
In a study in patients with renal impairment, including end-stage renal disease, no clinically relevant change in semaglutide pharmacokinetics was observed [see Clinical Pharmacology (12.3)]
For nearly 7 years and over 20 million consultations on our platform since our founding, weve taken this customer-centric approach with all kinds of sensitive, challenging conditions: breaking down barriers to accessing care, whether through raising awareness, removing stigma, improving access channels, and meaningfully lowering the cost of high-quality care
Specifically, the FDA has not approved Ozempic for weight loss, but those with Type 2 Diabetes that use this drug, tend to slim down